相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How is genetic testing evaluated? A systematic review of the literature
Erica Pitini et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families
Belinda Vicuna et al.
JOURNAL OF COMMUNITY GENETICS (2018)
Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders
Edward J. Romasko et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care
K. N. Lazaridis
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families
Kristina G. Flores et al.
JOURNAL OF GENETIC COUNSELING (2017)
EXAMINING EVIDENCE IN US PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS
James D. Chambers et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2017)
Clinical utility of a 377 gene custom next-generation sequencing epilepsy panel
Jen Bevilacqua et al.
JOURNAL OF GENETICS (2017)
Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative
Julia R. Trosman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory
Teresa T. Vo et al.
PHARMACOTHERAPY (2017)
Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk
Erin O'Leary et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing
Amy E. Murphy et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems
J. A. Luzum et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition
Anosheh Afghahi et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting
Lisa C. Brown et al.
CLINICAL THERAPEUTICS (2017)
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C. H. van der Wouden et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The value of routine pharmacogenomic screeningAre we there yet? A perspective on the costs and benefits of routine screeningshouldn't everyone have this done?
D. L. Veenstra
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Review of Commercially Available Epilepsy Genetic Panels
Chelsea Chambers et al.
JOURNAL OF GENETIC COUNSELING (2016)
Genetic Variation Among 82 Pharmacogenes: The PGRNseq Data From the eMERGE Network
W. S. Bush et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Routine use of gene panel testing in hereditary breast cancer should be performed with caution
Cedric van Marcke et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Evaluation of laboratory perspectives on hereditary cancer panels
Jessica Stoll et al.
FAMILIAL CANCER (2016)
Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer
Nimmi S. Kapoor et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk
Thaddeus Judkins et al.
BMC CANCER (2015)
Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines
Rebecca K. Marcus et al.
FAMILIAL CANCER (2015)
A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients
Stephen E. Lincoln et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Pharmacogenomics in the clinic
Mary V. Relling et al.
NATURE (2015)
Availability and payer coverage of BRCA1/2 tests and gene panels
Elizabeth Clain et al.
NATURE BIOTECHNOLOGY (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Economic Analysis of Rapid and Sensitive Polymerase Chain Reaction Testing in the Emergency Department for Influenza Infections in Children
Richard E. Nelson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond et al.
JAMA ONCOLOGY (2015)
The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes
Joachim Benitez et al.
APPLIED AND TRANSLATIONAL GENOMICS (2015)
Adoption of a clinical pharmacogenomics implementation program during outpatient care-initial results of the University of Chicago 1,200 Patients Project
Peter H. O'Donnell et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2014)
The emerging era of pharmacogenomics: current successes, future potential, and challenges
J. W. Lee et al.
CLINICAL GENETICS (2014)
Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing
A. C. J. W. Janssens et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice
Christina G. Selkirk et al.
FAMILIAL CANCER (2014)
Points to Consider in the Clinical Use of NGS Panels for Mitochondrial Disease: An Analysis of Gene Inclusion and Consent Forms
Julia Platt et al.
JOURNAL OF GENETIC COUNSELING (2014)
Gene Panel Testing for Inherited Cancer Risk
Michael J. Hall et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Tumor sequencing takes off, but insurance reimbursement lags
Shraddha Chakradhar
NATURE MEDICINE (2014)
Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time-Using Genomic Data to Individualize Treatment Protocol
Suzette J. Bielinski et al.
MAYO CLINIC PROCEEDINGS (2014)
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Munir Pirmohamed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The AmpliChip (TM) CYP450 Genotyping Test - Integrating a new clinical tool
Jose de Leon et al.
MOLECULAR DIAGNOSIS & THERAPY (2006)
分享论文
